June 2022 - Xtalks

Wednesday, August 12, 2026 | 11am EDT: Accelerate Cell Culture Media Development with Automated Cell Analysis

Fibrillar Collagen Wound Dressing by Collagen Matrix Secures the Company Its 40th FDA 510(k) Clearance

Breyanzi (lisocabtagene maraleucel) Gets FDA Approval for Relapsed or Refractory LBCL After One Prior Therapy

Drug Development for Rare Neurodegenerative Diseases Can be Accelerated with the FDA’s New Action Plan

Life Science News

BD Announced Voluntary Recall for Intraosseous Products

Diagnostics News

Monkeypox Test Kit in Development by Becton Dickinson in Partnership with CerTest Biotec

Tafinlar and Mekinist Combination Approved by FDA for Solid Tumors with BRAF V600E Mutation

These are the Best Condiments According to Whole Foods Market Trends Council

FDA Authorizes Pfizer and Moderna COVID-19 Vaccines for Children Under Five After Unanimous Advisory Panel Support

Eli Lilly’s Olumiant FDA Approved for Alopecia + Alnylam’s RNAi Drug Amvuttra Approved for Rare Protein Disorder – Xtalks Life Science Podcast Ep. 66

New Jack and Coke in a Can + Mars’ Animal-Free, Planet-Friendly Chocolate Bar – Xtalks Food Podcast Ep. 66

Hydroponic Lettuce Grower Little Leaf Farms Raises $300 Million

Getting Cancer Cell Therapies to Patients: Insights from a Biopharma Industry Veteran

The Benefits of an Augmented Consumer Platform Purpose-Built for the Life Sciences

CO2COA is Mars’ Latest Animal-Free, Planet-Friendly Chocolate Bar

Amvuttra RNAi Therapeutic Wins FDA Approval for Rare Genetic Protein Disorder

Clinical Trial News

Sacral Nerve Stimulation Study with Neuspera’s Nuvella System Moves into Second Phase

Next Page »